U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Mammary Tumorigenesis

MedGen UID:
269149
•Concept ID:
C1512981
•
Neoplastic Process

Definition

Production of a new growth or growths in the mammary gland. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVMammary Tumorigenesis

Professional guidelines

PubMed

Toxicity endpoint selections for a simazine risk assessment.
Silva M, Iyer P
Birth Defects Res B Dev Reprod Toxicol 2014 Aug;101(4):308-24. Epub 2014 Jul 30 doi: 10.1002/bdrb.21114. PMID: 25078261
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
Liby K, Risingsong R, Royce DB, Williams CR, Yore MM, Honda T, Gribble GW, Lamph WW, Vannini N, Sogno I, Albini A, Sporn MB
Clin Cancer Res 2008 Jul 15;14(14):4556-63. doi: 10.1158/1078-0432.CCR-08-0040. PMID: 18628471Free PMC Article
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ
Endocr Relat Cancer 2001 Jun;8(2):97-114. doi: 10.1677/erc.0.0080097. PMID: 11397667

Recent clinical studies

Etiology

Dysregulation of splicing variants and spliceosome components in breast cancer.
Gahete MD, Herman-Sanchez N, Fuentes-Fayos AC, Lopez-Canovas JL, Luque RM
Endocr Relat Cancer 2022 Sep 1;29(9):R123-R142. Epub 2022 Aug 1 doi: 10.1530/ERC-22-0019. PMID: 35728261
RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors.
Patel PS, Abraham KJ, Guturi KKN, Halaby MJ, Khan Z, Palomero L, Ho B, Duan S, St-Germain J, Algouneh A, Mateo F, El Ghamrasni S, Barbour H, Barnes DR, Beesley J, Sanchez O, Berman HK, Brown GW, Affar EB, Chenevix-Trench G, Antoniou AC, Arrowsmith CH, Raught B, Pujana MA, Mekhail K, Hakem A, Hakem R
J Clin Invest 2021 Feb 1;131(3) doi: 10.1172/JCI140105. PMID: 33529165Free PMC Article
p16INK4a suppresses BRCA1-deficient mammary tumorigenesis.
Scott A, Bai F, Chan HL, Liu S, Ma J, Slingerland JM, Robbins DJ, Capobianco AJ, Pei XH
Oncotarget 2016 Dec 20;7(51):84496-84507. doi: 10.18632/oncotarget.13015. PMID: 27811360Free PMC Article
Progesterone regulation of stem and progenitor cells in normal and malignant breast.
Axlund SD, Sartorius CA
Mol Cell Endocrinol 2012 Jun 24;357(1-2):71-9. Epub 2011 Sep 16 doi: 10.1016/j.mce.2011.09.021. PMID: 21945473Free PMC Article
Fat and cancer.
Carroll KK, Braden LM, Bell JA, Kalamegham R
Cancer 1986 Oct 15;58(8 Suppl):1818-25. doi: 10.1002/1097-0142(19861015)58:8+<1818::aid-cncr2820581406>3.0.co;2-4. PMID: 3756806

Diagnosis

Dysregulation of splicing variants and spliceosome components in breast cancer.
Gahete MD, Herman-Sanchez N, Fuentes-Fayos AC, Lopez-Canovas JL, Luque RM
Endocr Relat Cancer 2022 Sep 1;29(9):R123-R142. Epub 2022 Aug 1 doi: 10.1530/ERC-22-0019. PMID: 35728261
Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.
Sun H, Zeng J, Miao Z, Lei KC, Huang C, Hu L, Su SM, Chan UI, Miao K, Zhang X, Zhang A, Guo S, Chen S, Meng Y, Deng M, Hao W, Lei H, Lin Y, Yang Z, Tang D, Wong KH, Zhang XD, Xu X, Deng CX
Theranostics 2021;11(20):9967-9987. Epub 2021 Oct 25 doi: 10.7150/thno.63995. PMID: 34815798Free PMC Article
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy.
Lei JH, Lee MH, Miao K, Huang Z, Yao Z, Zhang A, Xu J, Zhao M, Huang Z, Zhang X, Chen S, Jiaying NG, Feng Y, Xing F, Chen P, Sun H, Chen Q, Xiang T, Chen L, Xu X, Deng CX
Adv Sci (Weinh) 2021 Nov;8(21):e2100974. Epub 2021 Sep 13 doi: 10.1002/advs.202100974. PMID: 34514747Free PMC Article
Noncanonical TGF-β signaling during mammary tumorigenesis.
Parvani JG, Taylor MA, Schiemann WP
J Mammary Gland Biol Neoplasia 2011 Jun;16(2):127-46. Epub 2011 Mar 31 doi: 10.1007/s10911-011-9207-3. PMID: 21448580Free PMC Article
The ras signaling pathway in mammary tumorigenesis and metastasis.
Malaney S, Daly RJ
J Mammary Gland Biol Neoplasia 2001 Jan;6(1):101-13. doi: 10.1023/a:1009572700317. PMID: 11467446

Therapy

Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy.
Lei JH, Lee MH, Miao K, Huang Z, Yao Z, Zhang A, Xu J, Zhao M, Huang Z, Zhang X, Chen S, Jiaying NG, Feng Y, Xing F, Chen P, Sun H, Chen Q, Xiang T, Chen L, Xu X, Deng CX
Adv Sci (Weinh) 2021 Nov;8(21):e2100974. Epub 2021 Sep 13 doi: 10.1002/advs.202100974. PMID: 34514747Free PMC Article
Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.
Zambrano JN, Neely BA, Yeh ES
Pharmacol Res 2017 May;119:188-194. Epub 2017 Feb 9 doi: 10.1016/j.phrs.2017.02.007. PMID: 28189783Free PMC Article
PIN1 in breast development and cancer: a clinical perspective.
Rustighi A, Zannini A, Campaner E, Ciani Y, Piazza S, Del Sal G
Cell Death Differ 2017 Feb;24(2):200-211. Epub 2016 Nov 11 doi: 10.1038/cdd.2016.122. PMID: 27834957Free PMC Article
Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer.
Rangel MC, Bertolette D, Castro NP, Klauzinska M, Cuttitta F, Salomon DS
Breast Cancer Res Treat 2016 Apr;156(2):211-26. Epub 2016 Mar 11 doi: 10.1007/s10549-016-3746-7. PMID: 26968398Free PMC Article
Fat and cancer.
Carroll KK, Braden LM, Bell JA, Kalamegham R
Cancer 1986 Oct 15;58(8 Suppl):1818-25. doi: 10.1002/1097-0142(19861015)58:8+<1818::aid-cncr2820581406>3.0.co;2-4. PMID: 3756806

Prognosis

Dysregulation of splicing variants and spliceosome components in breast cancer.
Gahete MD, Herman-Sanchez N, Fuentes-Fayos AC, Lopez-Canovas JL, Luque RM
Endocr Relat Cancer 2022 Sep 1;29(9):R123-R142. Epub 2022 Aug 1 doi: 10.1530/ERC-22-0019. PMID: 35728261
Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism.
Mohapatra BC, Mirza S, Bele A, Gurumurthy CB, Raza M, Saleem I, Storck MD, Sarkar A, Kollala SS, Shukla SK, Southekal S, Wagner KU, Qiu F, Lele SM, Alsaleem MA, Rakha EA, Guda C, Singh PK, Cardiff RD, Band H, Band V
Mol Cancer Res 2022 Sep 2;20(9):1391-1404. doi: 10.1158/1541-7786.MCR-22-0122. PMID: 35675041Free PMC Article
Autophagy in stromal fibroblasts promotes tumor desmoplasia and mammary tumorigenesis.
Rudnick JA, Monkkonen T, Mar FA, Barnes JM, Starobinets H, Goldsmith J, Roy S, Bustamante Eguiguren S, Weaver VM, Debnath J
Genes Dev 2021 Jul 1;35(13-14):963-975. Epub 2021 Jun 24 doi: 10.1101/gad.345629.120. PMID: 34168038Free PMC Article
TGIF function in oncogenic Wnt signaling.
Razzaque MS, Atfi A
Biochim Biophys Acta 2016 Apr;1865(2):101-4. Epub 2015 Nov 11 doi: 10.1016/j.bbcan.2015.10.003. PMID: 26522669
MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.
Callahan R, Smith GH
Oncogene 2000 Feb 21;19(8):992-1001. doi: 10.1038/sj.onc.1203276. PMID: 10713682

Clinical prediction guides

Tumor-educated T(regs) drive organ-specific metastasis in breast cancer by impairing NK cells in the lymph node niche.
Kos K, Aslam MA, van de Ven R, Wellenstein MD, Pieters W, van Weverwijk A, Duits DEM, van Pul K, Hau CS, Vrijland K, Kaldenbach D, Raeven EAM, Quezada SA, Beyaert R, Jacobs H, de Gruijl TD, de Visser KE
Cell Rep 2022 Mar 1;38(9):110447. doi: 10.1016/j.celrep.2022.110447. PMID: 35235800
Transgenic mouse models of breast cancer.
Regua AT, Arrigo A, Doheny D, Wong GL, Lo HW
Cancer Lett 2021 Sep 28;516:73-83. Epub 2021 Jun 6 doi: 10.1016/j.canlet.2021.05.027. PMID: 34090924Free PMC Article
Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.
Liu B, Liu Z, Chen S, Ki M, Erickson C, Reis-Filho JS, Durham BH, Chang Q, de Stanchina E, Sun Y, Rabadan R, Abdel-Wahab O, Chandarlapaty S
J Clin Invest 2021 Jan 4;131(1) doi: 10.1172/JCI138315. PMID: 33031100Free PMC Article
It takes two to tango in the microenvironment!
Ursini-Siegel J, Park M
Breast Cancer Res 2013 Mar 12;15(2):102. doi: 10.1186/bcr3388. PMID: 23510134Free PMC Article
MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways.
Callahan R, Smith GH
Oncogene 2000 Feb 21;19(8):992-1001. doi: 10.1038/sj.onc.1203276. PMID: 10713682

Recent systematic reviews

The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review.
de Groot AF, Appelman-Dijkstra NM, van der Burg SH, Kroep JR
Cancer Treat Rev 2018 Jan;62:18-28. Epub 2017 Nov 2 doi: 10.1016/j.ctrv.2017.10.010. PMID: 29154022
Alcohol consumption and cancer risk: understanding possible causal mechanisms for breast and colorectal cancers.
Oyesanmi O, Snyder D, Sullivan N, Reston J, Treadwell J, Schoelles KM
Evid Rep Technol Assess (Full Rep) 2010 Nov;(197):1-151. PMID: 23126574Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...